Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epiduo in the Long-term Treatment of Moderate to Severe Acne With or Without Concomitant Medication

NCT01618773 is registered in ClinicalTrials.gov with Galderma Laboratorium GmbH as lead sponsor.

NCT NCT01618773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01618773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epiduo in the Long-term Treatment of Moderate to Severe Acne With or Without Concomitant Medication
Lead sponsor
Galderma Laboratorium GmbH
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
September 30, 2013
Enrollment
6,036 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris